Thioredoxin 80-activated-monocytes (TAMs) inhibit the replication of intracellular pathogens

Research output: Contribution to journalJournal articleResearchpeer-review

  • Ximena Cortes-Bratti
  • Eugénie Bassères
  • Fabiola Herrera-Rodriguez
  • Silvia Botero-Kleiven
  • Giuseppe Coppotelli
  • Andersen, Jens Bo
  • Maria G Masucci
  • Arne Holmgren
  • Esteban Chaves-Olarte
  • Teresa Frisan
  • Javier Avila-Cariño
Thioredoxin 80 (Trx80) is an 80 amino acid natural cleavage product of Trx, produced primarily by monocytes. Trx80 induces differentiation of human monocytes into a novel cell type, named Trx80-activated-monocytes (TAMs).
Original languageEnglish
JournalPloS one
Volume6
Issue number2
Pages (from-to)e16960
ISSN1932-6203
DOIs
Publication statusPublished - 2011

    Research areas

  • Blood-Borne Pathogens, Brucella abortus, Cell Compartmentation, Cell Division, Cells, Cultured, Colony Count, Microbial, Down-Regulation, Drug Evaluation, Preclinical, Humans, Intracellular Space, Listeria monocytogenes, Microbial Viability, Monocytes, Peptide Fragments, Phagocytosis, Thioredoxins

ID: 46498776